The art of successful licensing – “A lot has to align”

Sharp research, strong data and a high level of innovation are all very good, but more than that is required to achieve the goal of many biotechnology companies...

Introducing ZEISS arivis Pro 4.2

Your solution for advanced image analysis and visualization.

Meet us at Control 2025

Innovations that drive efficiency.

Introducing ZEISS arivis Pro 4.2

ZEISS arivis software enhances custom microscopy image analysis.

Anna Törner: ”Varför inte slå till på en ADHD-diagnos till kampanjpris?”

”Det är självklart positivt att neuropsykiatriska diagnoser inte upplevs som stigmatiserande, men just när det gäller ADHD kan jag inte låta bli att undra om de...

Mikael Kubista back with new venture after turbulent exit

Entrepreneur and researcher Mikael Kubista is starting a new company. Now he is also free to comment on the sequence of events that led to him losing ownership ...

Advancing Drug Discovery by Combining Complex In-Vitro Models with AI-Powered 3D/4D Image Analysis

Free webinar organized by ZEISS.

Controlled Pneumatics: pushing the boundaries of pneumatics

Pressure, flow rate and movement can now be controlled very precisely, and with exactly the energy actually required. Controlled Pneumatics is the combination o...

ZEISS Quality Innovations at CONTROL

May 6-9, 2025 in Stuttgart.

After the threat of tariffs – Novartis invests 230 billion in the USA

Pharmaceutical giant Novartis plans to invest 23 billion dollarsover the next five years to expand its production in the USA. The goal is for all medicines dest...

Wegovy godkänt i USA för behandling av leversjukdom

Den amerikanska läkemedelsmyndigheten FDA har beviljat ett påskyndat godkännande för Novo Nordisks läkemedel Wegovy vid behandling av den allvarliga leversjukdo...

BMS and venture capital giant form new company

The American pharmaceutical company Bristol Myers Squibb, together with the venture capital firm Bain Capital, is forming a new biotech company. The company wil...

Wegovy approved in the U.S. for treatment of liver disease

The U.S. Food and Drug Administration (FDA) has granted accelerated approval for Novo Nordisk’s drug Wegovy to treat the serious liver condition known as MASH. ...

Novo Nordisk establishes new factory in Denmark

Novo Nordisk establishes a new production facility in Odense, Denmark, an investment of 8.5 billion Danish kroner.

Innovative start-up helps doctors, scientists and industry balance coagulation risks

For many doctors caring for seriously ill patients, for example, in stroke units and cancer wards, maintaining the life-saving balance between bleeding and thro...

JMP Statistical Discovery

Sahlgrenska Science Park

Peter Hovstadius är ny medicinsk chef på Lif

Läkaren Peter Hovstadius har utsetts till Chief Medical Officer på branschorganisationen Lif – de forskande läkemedelsföretagen.

Efter Trumps nedskärningar – nu ska EU locka över amerikanska toppforskare

USA drar in på statliga forskningsanslag – då ser europeiska aktörer sin chans att locka till sig forskarbegåvningar från andra sidan Atlanten.

Zelmic

Svenska forskare fann ”mellanform av parkinson och alzheimer”

Vissa patienter som får diagnosen Parkinsons sjukdom kan i själva verket ha en annan sjukdom som snarare liknar alzheimer. Det enligt en ny studie från Umeå och...

We desire talent to come here, but are we genuinely welcoming them?

Sweden faces significant challenges in creating a truly inclusive environment that makes international professionals feel welcome, valued, and able to build mea...

Pneumatics Makes a Technological Leap with Piezo

The first high-precision proportional valve terminal VTEP opens up new application areas

Pharma Outsourcing – Find the Right Partner (2026)